Certified by Founder Lodge
Pathalys Pharma
United States - Raleigh, North Carolina
START UP
1 Disclosed Funding Rounds $150,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chro
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 07 ,2023 | Unknown | $150,000,000 | |
| August, 21 ,2024 | Series B | $105,000,000.00 |
OrbiMed
The Carlyle Group
Abingworth
Catalys Pacific
DaVita Venture Group
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
